A detailed history of Lafayette Investments, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Lafayette Investments, Inc. holds 7,857 shares of DHR stock, worth $2.12 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
7,857
Previous 7,877 0.25%
Holding current value
$2.12 Million
Previous $1.97 Million 0.2%
% of portfolio
0.45%
Previous 0.44%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$235.51 - $267.98 $4,710 - $5,359
-20 Reduced 0.25%
7,857 $1.96 Million
Q1 2024

May 09, 2024

SELL
$224.58 - $256.19 $17,966 - $20,495
-80 Reduced 1.01%
7,877 $1.97 Million
Q4 2023

Jan 31, 2024

BUY
$185.1 - $233.13 $78,667 - $99,080
425 Added 5.64%
7,957 $1.84 Million
Q2 2023

Jul 24, 2023

SELL
$224.99 - $256.14 $56,247 - $64,035
-250 Reduced 3.21%
7,532 $1.81 Million
Q4 2022

Jan 24, 2023

SELL
$241.42 - $282.29 $3,621 - $4,234
-15 Reduced 0.19%
7,782 $0
Q3 2022

Oct 28, 2022

SELL
$247.06 - $1507.4 $137,118 - $836,607
-555 Reduced 6.65%
7,797 $2.01 Million
Q2 2022

Jul 27, 2022

SELL
$237.11 - $299.66 $137,523 - $173,802
-580 Reduced 6.49%
8,352 $2.12 Million
Q1 2022

May 11, 2022

BUY
$257.27 - $315.76 $520,971 - $639,414
2,025 Added 29.32%
8,932 $2.62 Million
Q4 2021

Feb 10, 2022

BUY
$292.08 - $329.01 $156,262 - $176,020
535 Added 8.4%
6,907 $2.27 Million
Q2 2021

Aug 10, 2021

BUY
$225.08 - $271.69 $1.2 Million - $1.45 Million
5,350 Added 523.48%
6,372 $1.71 Million
Q1 2021

May 12, 2021

SELL
$212.38 - $245.9 $42,476 - $49,180
-200 Reduced 16.37%
1,022 $230,000
Q3 2020

Oct 30, 2020

SELL
$177.16 - $215.33 $17,716 - $21,533
-100 Reduced 7.56%
1,222 $263,000
Q2 2020

Aug 05, 2020

BUY
$128.7 - $176.83 $170,141 - $233,769
1,322 New
1,322 $234,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $197B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Lafayette Investments, Inc. Portfolio

Follow Lafayette Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lafayette Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lafayette Investments, Inc. with notifications on news.